Royalty Pharma plc

RPRX · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$929,026$477,010$1,710,751$1,541,048
Short-Term Investments$841,970$756,738$717,040$1,262,223
Receivables$26,956$22,405$36,597$68,309
Inventory$0$0$0$0
Other Curr. Assets$4,187$18,040$90,520$6,631
Total Curr. Assets$1,802,139$1,274,193$2,554,908$2,878,211
Property Plant & Equip (Net)$0$0$0$0
Goodwill$0$0$0$0
Intangibles$15,127,158$0$0$5,670
Long-Term Investments$16,387,042$15,101,136$14,228,929$14,627,839
Tax Assets$0$0$0$0
Other NC Assets-$15,093,624$6,522$29,629$4,145
Total NC Assets$16,420,576$15,107,658$14,258,558$14,637,654
Other Assets$0$0$0$0
Total Assets$18,222,715$16,381,851$16,813,466$17,515,865
Liabilities
Payables$13,370$15,165$7,906$5,620
Short-Term Debt$997,773$0$997,512$0
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$242,473$146,212$161,365$165,630
Total Curr. Liab.$1,253,616$161,377$1,166,783$171,250
LT Debt$6,614,653$6,135,285$6,118,810$7,096,070
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$12,080$900$2,500$0
Total NC Liab.$6,626,733$6,136,185$6,121,310$7,096,070
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$7,880,349$6,297,562$7,288,093$7,267,320
Equity
Pref Stock$0$0$0$0
Common Stock$108$108$107$106
Retained Earnings$2,845,653$2,517,583$1,964,689$2,255,179
AOCI$0$0$0$16,491
Other Equity$4,100,820$4,008,806$3,663,354$3,504,818
Total Equity$6,946,581$6,526,497$5,628,150$5,776,594
Supplemental Information
Minority Interest$3,395,785$3,557,792$3,897,223$4,471,951
Total Liab. & Tot. Equity$18,222,715$16,381,851$16,813,466$17,515,865
Net Debt$6,683,400$5,658,275$5,405,571$5,555,022